IGC Pharma unveils PRISM AI platform
IGC Pharma says the platform is intended to advance Alzheimer’s risk prediction toward brain-health action and commercial deployment.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
IGC Pharma says the platform is intended to advance Alzheimer’s risk prediction toward brain-health action and commercial deployment.